ARCHIVES

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography

February 14, 1997